The expansion of LENTIVERSE™ platform introduces "One Lentiviral Vector Platform, Two Paths to Advance Cures," aligning scientific rigor with transparent ...
In this webinar, Brian Haldeman will discuss how Leprechaun enables complete biophysical characterization of in-process or ...
For kids with the condition, day-to-day activities like going to school or playing with friends can lead to life-threatening ...
There are a number of considerations that can help streamline the pathway to the clinic. One of the first is which vector ...
Prime Minister Narendra Modi gifted three path-breaking innovations, including CART-T Cell Therapy, India''s first indigemous cancer cell therapy developed by Indian Innovators with the support of the ...
Qihan Biotech, a biotechnology company founded by Dr. Luhan Yang and Dr. George Church, is harnessing multiplex genome ...
OXB to participate in upcoming investor conferences and events Oxford, UK – 27 October 2025: OXB (LSE: OXB), a global quality ...
About OXB OXB (LSE: OXB) is a global quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life ...
Countable Labs, the developer of Countable PCR, the leading PCR innovation transforming how science measures biology, announced the launch of the RNA Module for Countable PCR. This new solution brings ...
The primary safety end points included the incidence and type of delayed serious adverse events, such as hospitalizations, infections, autoimmunity, hematologic disorders, and neurologic complications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback